Skip to main content
LIFD
OTC Life Sciences

LFTD Partners Closes $1.5M Kenosha Building Sale, Repays All Bank Debt

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.101
Mkt Cap
$1.497M
52W Low
$0.071
52W High
$1.1
52W Position info
42% above low
Off High info
91% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

LIFD sits 42% above its 52-week low of $0.071.

Summary

LFTD Partners closed the $1.5 million sale of its Kenosha building, repaid all outstanding bank debt, and now holds over $2.4 million in cash — more than its market cap.


Key Events · M&A and Partnerships · LIFD

  • Building Sale Closed

    On September 29, 2026, Lifted Made completed the sale of the 5511 Building in Kenosha, WI to Ad Real Estate Group LLC for $1.5 million in cash.

  • All Bank Debt Repaid

    The company used $841,109.63 of the proceeds to pay off the Building Loan from Surety Bank, including a $9,100 prepayment penalty. The company now has no remaining bank debt.

  • Net Proceeds and Cash Position

    After loan payoff, $45,000 brokerage commission, transfer taxes, and closing costs, net cash proceeds were $592,485.36. The company holds more than $2.4 million in cash, exceeding its market cap by nearly $1 million.

  • Going Concern Context

    This liquidity event follows the August 10-Q warning that the company may not continue as a going concern due to upcoming federal hemp restrictions. The cash provides runway to navigate regulatory uncertainty.


Analysis · LIFD · Life Sciences

The completed sale of its former headquarters for $1.5 million allowed LFTD Partners to repay its only bank loan with $841,110 of the proceeds. The company now holds more than $2.4 million in cash — exceeding its entire stock market capitalization by nearly $1 million, according to the CFO. This is a meaningful liquidity event for a company that warned in August it may not continue as a going concern due to upcoming federal hemp restrictions. The cash provides runway to navigate regulatory uncertainty, though the company has not yet determined whether the sale will result in a net gain or loss.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LIFD was trading at $0.10 on OTC in the Life Sciences sector, with a market capitalization of approximately $1.5M. The 52-week trading range was $0.07 to $1.10. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LIFD - Latest Insights

LIFD
Aug 14, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.194
Real-time Price: $0.110 info
Change: -$0.084 (-43%) info
Market Cap: $1.63M info
LIFD
Jul 24, 2026, 11:14 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.1979
Real-time Price: $0.110 info
Change: -$0.0879 (-44%) info
Market Cap: $1.63M info
LIFD
Jun 30, 2026, 6:44 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $0.162638
Real-time Price: $0.110 info
Change: -$0.052638 (-32%) info
Market Cap: $1.63M info
LIFD
May 14, 2026, 5:42 PM EDT
Filing Type: 10-Q
Importance Score:
10
Price at Filing: $0.180
Real-time Price: $0.110 info
Change: -$0.070 (-39%) info
Market Cap: $1.63M info
LIFD
Mar 31, 2026, 8:17 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.240
Real-time Price: $0.110 info
Change: -$0.130 (-54%) info
Market Cap: $1.63M info